Nerve growth factor protects retinal ganglion cells against injury induced by retinal ischemia–reperfusion in rats

References

• Arai-Gaun S, Katai N, Kikuchi T, Kurokawa T, Ohta K, Yoshimura N. 2004. Oxygenase-1 induced in muller cells plays a protective role in retinal ischemia-reperfusion injury in rats. Invest Ophthalmol Vis Sci 45:4226–4232
   PubMed Web of Science ®Google Scholar
• Burch ML, Zheng W, Little PJ. 2011. Smad linker region phosphorylation in the regulation of extracellular matrix synthesis. Cell Mol Life Sci 68(1):97–107
   PubMed Web of Science ®Google Scholar
• Carmignoto G, Maffei L, Candeo P, Canella R, Comelli C. 1989. Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section. J Neurosci 9:1263–1272
   PubMed Web of Science ®Google Scholar
• Casaccia-Bonnefil P, Carter BD, Dobrowsky RT, Chao MV. 1996. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature 383:716–719
   PubMed Web of Science ®Google Scholar
• Cellerino A, Michaelidis T, Barski JJ, Bähr M, Thoenen H, Meyer M. 1999. Retinal ganglion cell loss after the period of naturally occurring cell death in bcl-2-/-mice. Neuroreport 10:1091–1095
   PubMed Web of Science ®Google Scholar
• Colafrancesco V, Parisi V, Sposato V, Rossi S, Russo MA, Coassin M, Lambiase A, et al. 2011. Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma. J Glaucoma 20:100–108
   PubMed Web of Science ®Google Scholar
• Deponti D, Buono R, Catanzaro G, De Palma C, Longhi R, Meneveri R, Bresolin N, et al. 2009. The low-affinity receptor for neurotrophins p75NTR plays a key role for satellite cell function in muscle repair acting via RhoA. Mol Biol Cell 20:3620–3627
   PubMed Web of Science ®Google Scholar
• Dietz GP, Kilic E, Bähr M, Isenmann S. 2001. Bcl-2 is not required in retinal ganglion cells surviving optic nerve axotomy. Neuroreport 12:3353–3356
   PubMed Web of Science ®Google Scholar
• Dussmann H, Rehm M, Concannon CG, Anguissola S, Würstle M, Kacmar S, Völler P, et al. 2010. Single-cell quantification of Bax activation and mathematical modelling suggest pore formation on minimal mitochondrial Bax accumulation. Cell Death Differ 17:278–290
   PubMed Web of Science ®Google Scholar
• Ebisuya M, Kondoh K, Nishida E. 2005. The duration, magnitude and compartmentalization of ERK MAP kinase activity: Mechanisms for providing signaling specificity. J Cell Sci 118(Pt 14):2997–3002
   PubMed Web of Science ®Google Scholar
• Frade JM, Rodriguez-Tebar A, Barde YA. 1996. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 383:166–168
   PubMed Web of Science ®Google Scholar
• Gan L, Zheng W, Chabot JG, Unterman TG, Quirion R. 2005. Nuclear/cytoplasmic shuttling of the transcription factor FoxO1 is regulated by neurotrophic factors. J Neurochem 93(5):1209–1219
   PubMed Web of Science ®Google Scholar
• García-Sáez AJ. 2012. The secrets of the Bcl-2 family. Cell Death Differ 19:1733–1740
   PubMed Web of Science ®Google Scholar
• Ivanisevic L, Zheng W, Woo SB, Neet KE, Saragovi HU. 2007. TrkA receptor “hot spots” for binding of NT-3 as a heterologous ligand. J Biol Chem 282:16754–16763
   PubMedGoogle Scholar
• Kamato D, Burch ML, Piva TJ, Rezaei HB, Rostam MA, Xu S, Zheng W, et al. 2013. Transforming growth factor-β signalling: Role and consequences of Smad linker region phosphorylation. Cell Signal 25:2017–2024
   PubMed Web of Science ®Google Scholar
• Ko ML, Chen CF, Peng PH, Peng YH. 2011. Simvastatin upregulates Bcl-2 expression and protects retinal neurons from early ischemia/reperfusion injury in the rat retina. Exp Eye Res 93:580–585
   PubMed Web of Science ®Google Scholar
• Lai TW, Zhang S, Wang YT. 2014. Excitotoxicity and stroke: Identifying novel targets for neuroprotection. Prog Neurobiol 115:157–188
   PubMed Web of Science ®Google Scholar
• Lambiase A, Aloe L. 1996. Nerve growth factor delays retinal degeneration in C3H mice. Graefes Arch Clin Exp Ophthalmol 234:S96–S100
   PubMed Web of Science ®Google Scholar
• Lambiase A, Aloe L, Centofanti M, Parisi V, Mantelli F, Colafrancesco V, Manni GL. 2009. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma. Proc Natl Acad Sci USA 106:13469–13474
   PubMed Web of Science ®Google Scholar
• Lambiase A, Centofanti M, Micera A, Manni GL, Mattei E, De Gregorio A, de Feo G, et al. 1997. Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension. Graefes Arch Clin Exp Ophthalmol 235:780–785
   PubMed Web of Science ®Google Scholar
• Lambiase A, Mantelli F, Bonini S. 2010. Nerve growth factor eye drops to treat glaucoma. Drug News Perspect 23:361–367
   PubMedGoogle Scholar
• Lenzi L, Coassin M, Lambiase A, Bonini S, Amendola T, Aloe L. 2005. Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa. Vision Res 45:1491–1500
   PubMed Web of Science ®Google Scholar
• Libby RT, Li Y, Savinova OV, Barter J, Smith RS, Nickells RW, John SW. 2005. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet 1:17–26
   PubMed Web of Science ®Google Scholar
• Li JB, Lu ZG, Xu L, Wang Q, Zhang ZH, Fang JH. 2014. Neuroprotective effects of Bis(7)-tacrine in a rat model of pressure-induced retinal ischemia. Cell Biochem Biophys 68:275–282
   PubMed Web of Science ®Google Scholar
• Ma L, Lei L, Eng SR, Turner E, Parada LF. 2003. Brn3a regulation of TrkA/NGF receptor expression in developing sensory neurons. Development 130:3525–3534
   PubMed Web of Science ®Google Scholar
• Manni L, Rocco ML, Bianchi P, Soligo M, Guaragna M, Barbaro SP, Aloe L. 2013. Nerve growth factor: Basic studies and possible therapeutic applications. Growth Factors 31(4):115–122
   PubMed Web of Science ®Google Scholar
• Mey J, Thanos S. 1993. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res 602:304–317
   PubMed Web of Science ®Google Scholar
• Micera A, Lambiase A, Aloe L, Bonini S, Levi-Schaffer F, Bonini S. 2004. Nerve growth factor involvement in the visual system: Implications in allergic and neurodegenerative diseases. Cytokine Growth Factor Rev 15:411–417
   PubMed Web of Science ®Google Scholar
• Negrini S, D'Alessandro R, Meldolesi J. 2013. NGF signaling in PC12 cells: The cooperation of p75(NTR) with TrkA is needed for the activation of both mTORC2 and the PI3K signalling cascade. Biol Open 2:855–866
   PubMed Web of Science ®Google Scholar
• Nishiwaki A, Ueda T, Ugawa S, Shimada S, Ogura Y. 2003. Upregulation of P-selectin and intercellular adhesion molecule-1 after retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 44:4931–4935
   PubMed Web of Science ®Google Scholar
• Qin Q, Patil K, Sharma SC. 2004. The role of Bax-inhibiting peptide in retinal ganglion cell apoptosis after optic nerve transection. Neurosci Lett 372:17–21
   PubMed Web of Science ®Google Scholar
• Romon R, Adriaenssens E, Lagadec C, Germain E, Hondermarck H, Le Bourhis X. 2010. Nerve growth factor promotes breast cancer angiogenesis by activating multiple pathways. Mol Cancer 9:157
   PubMed Web of Science ®Google Scholar
• Shi Z, Birman E, Saragovi HU. 2007. Neurotrophic rationale in glaucoma: A TrkA agonist, but not NGF or a p75 antagonist, protects retinal ganglion cells in vivo. Dev Neurobiol 67:884–894
   PubMed Web of Science ®Google Scholar
• Siliprandi R, Canella R, Carmignoto G. 1993. Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia. Invest Ophthalmol Vis Sci 34:3232–3245
   PubMed Web of Science ®Google Scholar
• Sun JC, Xu T, Zuo Q, Wang RB, Qi AQ, Cao WL, Sun AJ, et al. 2014. Hydrogen-rich saline promotes survival of retinal ganglion cells in a rat model of optic nerve crush. PLoS One 9:e99299
   PubMed Web of Science ®Google Scholar
• Wang B, Gao Y, Xiao Z, Chen B, Han J, Zhang J, Wang X, et al. 2009. Erk1 /2 promotes proliferation and inhibits neuronal differentiation of neural stem cells. Neurosci Lett 461:252–257
   PubMed Web of Science ®Google Scholar
• Westphal D, Dewson G, Czabotar PE, Kluck RM. 2011. Molecular biology of Bax and Bak activation and action. Bba-Mol Cell Res 1813:521–531
   PubMed Web of Science ®Google Scholar
• Yang JP, Liu XF, Liu HJ, Xu GL, Ma YP. 2008. Extracellular signal-regulated kinase involved in NGF/VEGF-induced neuroprotective effect. Neurosci Lett 434:212–217
   PubMed Web of Science ®Google Scholar
• Zhang C, Lam TT, Tso MO. 2005. Heterogeneous populations of microglia/macrophages in the retina and their activation after retinal ischemia and reperfusion injury. Exp Eye Res 81:700–709
   PubMed Web of Science ®Google Scholar
• Zhang YW, Chen Y, Liu Y, Zhao Y, Liao FF, Xu H. 2013. APP regulates NGF receptor trafficking and NGF-mediated neuronal differentiation and survival. PLoS One 8:e80571
   PubMed Web of Science ®Google Scholar
• Zheng WH, Kar S, Quirion R. 2002. FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling. J Neurochem 80:1049–1061
   PubMed Web of Science ®Google Scholar
• Zheng WH, Quirion R. 2009. Glutamate acting on N-methyl-d-aspartate receptors attenuates insulin-like growth factor-1 receptor tyrosine phosphorylation and its survival signaling properties in rat hippocampal neurons. J Biol Chem 284:855–861
   PubMed Web of Science ®Google Scholar
• Zheng WH, Quirion R. 2006. Insulin-like growth factor-1 (IGF-1) induces the activation/phosphorylation of Akt kinase and cAMP response element-binding protein (CREB) by activating different signaling pathways in PC12 cells. BMC Neurosci 7:51
   PubMed Web of Science ®Google Scholar
• Zheng W, Wang H, Zeng Z, Lin J, Little PJ, Srivastava LK, Quirion R. 2012. The possible role of the Akt signaling pathway in schizophrenia. Brain Res 1470:145–158
   PubMed Web of Science ®Google Scholar